In the second study (Fig. 1b), we continuously exposed wildtype (Wt) mice to rotenone and tested the effect of downregulating CPT1 by a pharmacological blocker following the induction of PD-like characteristics. The gene discussed is CPT1A; the disease is Parkinson disease.